Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates

Go back to Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates
HERON THERAPEUTICS (NASDAQ: HRTX) Delayed: 0.40 -0.01 (2.44%)
Previous Close $0.41    52 Week High $31.32 
Open $0.41    52 Week Low $13.95 
Day High $0.41    P/E N/A 
Day Low $0.40    EPS $-3.29 
Volume 4,557,507